Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)
CNY 7.43
(-9.06%)
CNY 7.43
(-9.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 533.23 Million | 659.19 Million | 574.71 Million | 544.72 Million | 500.5 Million | 536.98 Million |
| Cost of Revenue | 185.51 Million | 228.52 Million | 141.9 Million | 146.53 Million | 106.37 Million | 144 Million |
| Gross Profit | 347.72 Million | 430.66 Million | 432.8 Million | 398.19 Million | 394.12 Million | 392.97 Million |
| Operating Expenses | 307.2 Million | 375.96 Million | 403.22 Million | 365.15 Million | 384.64 Million | 346.08 Million |
| Selling, General and Administrative Expenses | 258.72 Million | 319.89 Million | 342.53 Million | 312.91 Million | 323.18 Million | 288.25 Million |
| Research and Development Expenses | 10.09 Million | 15.34 Million | 14.4 Million | 9.37 Million | 14.35 Million | 12.4 Million |
| Other Expenses | 4.11 Million | 40.73 Million | 46.28 Million | 42.86 Million | 47.11 Million | 492.74 Thousand |
| Cost and Expenses | 492.71 Million | 604.49 Million | 545.13 Million | 511.69 Million | 491.02 Million | 490.09 Million |
| Operating Income | 40.51 Million | 53.88 Million | 33.64 Million | 24.05 Million | 8.94 Million | 41.83 Million |
| Interest Expense | 445.34 | 454.16 Thousand | 1.01 Million | 3.72 Million | 3.45 Million | 1.8 Million |
| Income Tax Expense | 5.05 Million | 7.16 Million | 4.34 Million | 3.18 Million | 8 Million | 6.45 Million |
| Earnings before Tax | 39.37 Million | 51.09 Million | 5.82 Million | 23.02 Million | -114.18 Million | 42.33 Million |
| Net Income | 34.32 Million | 43.93 Million | 1.47 Million | 19.83 Million | -122.18 Million | 35.87 Million |
| Earnings Per Share Basic | 0.07 | 0.09 | 0.00 | 0.04 | -0.24 | 0.07 |
| Earnings Per Share Diluted | 0.07 | 0.09 | 0.00 | 0.04 | -0.24 | 0.07 |
| Weighted Average Shares Outstanding | 507.69 Million | 507.5 Million | 507.5 Million | 507.5 Million | 507.5 Million | 507.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 507.69 Million | 507.5 Million | 507.5 Million | 507.5 Million | 507.5 Million | 508.19 Million |
| Gross Margin | 0.65 | 0.65 | 0.75 | 0.73 | 0.79 | 0.73 |
| EBIT Margin | 0.12 | 0.12 | 0.11 | 0.11 | 0.07 | 0.14 |
| Profit Margin | 0.06 | 0.07 | 0.00 | 0.04 | -0.24 | 0.07 |
| EBITDA | 66.15 Million | 77.44 Million | 34.17 Million | 54.93 Million | -82.52 Million | 71.1 Million |
| Earnings Before Tax Margin | 0.08 | 0.08 | 0.06 | 0.04 | 0.02 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 77.86 Million | 85.78 Million | 94.41 Million | 156 Million | 533.23 Million | 119.81 Million |
| Cost of Revenue | 31.67 Million | 35.43 Million | 43.43 Million | 65.26 Million | 185.51 Million | 34.55 Million |
| Gross Profit | 46.19 Million | 50.35 Million | 50.97 Million | 90.73 Million | 347.72 Million | 85.25 Million |
| Operating Expenses | 47.94 Million | 51.13 Million | 45.84 Million | 80.51 Million | 310.4 Million | 78.37 Million |
| Selling, General and Administrative Expenses | 46.88 Million | 33.11 Million | 42.41 Million | 40.67 Million | - | 90.43 Million |
| Research and Development Expenses | 1.43 Million | 2.12 Million | 2.03 Million | 3.35 Million | - | 3.28 Million |
| Other Expenses | 372.58 Thousand | 168.75 Thousand | -4483.47 | -549.86 Thousand | -1.14 Million | 8115.88 |
| Cost and Expenses | 79.62 Million | 86.56 Million | 89.27 Million | 145.78 Million | 495.92 Million | 112.93 Million |
| Operating Income | -1.75 Million | 173.81 Thousand | 6.25 Million | 11.31 Million | 40.51 Million | 7.73 Million |
| Interest Expense | - | 126.47 | 86.07 | - | 445.34 | - |
| Income Tax Expense | 1 Million | -142.97 Thousand | 1.06 Million | 1.35 Million | 5.05 Million | 1.08 Million |
| Earnings before Tax | -767.88 Thousand | 342.57 Thousand | 6.25 Million | 10.76 Million | 39.37 Million | 7.74 Million |
| Net Income | -2.79 Million | 485.55 Thousand | 5.18 Million | 9.41 Million | 34.32 Million | 6.65 Million |
| Earnings Per Share Basic | -0.01 | 0.00 | 0.01 | 0.02 | - | 0.01 |
| Earnings Per Share Diluted | -0.01 | 0.00 | 0.01 | 0.02 | - | 0.01 |
| Weighted Average Shares Outstanding | 507.5 Million | 507.5 Million | 508.05 Million | 509.04 Million | 507.69 Million | 507.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 507.5 Million | 507.5 Million | 508.05 Million | 509.02 Million | 507.69 Million | 507.5 Million |
| Gross Margin | 0.59 | 0.59 | 0.54 | 0.58 | 0.65 | 0.71 |
| EBIT Margin | -0.01 | 0.02 | 0.05 | 0.08 | - | 0.05 |
| Profit Margin | -0.04 | 0.01 | 0.05 | 0.06 | 0.06 | 0.06 |
| EBITDA | -767.88 Thousand | 1.7 Million | 4.64 Million | 12.63 Million | - | 5.46 Million |
| Earnings Before Tax Margin | -0.02 | 0.00 | 0.07 | 0.07 | 0.08 | 0.06 |
8MI
2723
8093
6803
PHOENIXLTD
PTSP